Sankalp Ashok Gharat

Scopus Publications

Optimization of Nanostructured Lipid Carrier Using Central Composite Design for Ocular Delivery of Pirfenidone
Vivek Basudkar, Sankalp Gharat, Afiya Baig, Munira Momin
Journal of Pharmaceutical Innovation, 2026
Pharmacokinetic and dissolution profiling of tadalafil formulated with SNEDDS and β-cyclodextrin in fast-dissolving tablets
Cyril Jose, Sankalp Gharat, Afiya Baig, Pratibha Pilgaokar, Munira Momin
Drug Development and Industrial Pharmacy, 2026
One of the main challenges in the oral administration of tadalafil is its low water solubility, which limits its bioavailability. The research aims for enhancement of solubility and bioavailability for tadalafil, through comparing effectiveness for inclusion complex of Beta-cyclodextrin (β-CD) with self-nanoemulsifying drug delivery system (SNEEDS). Both approaches were further formulated into fast-dissolving tablets (FDTs) to achieve rapid onset of action. Dissolution studies demonstrated superior drug release from both systems compared to the marketed product, with SNEEDS showing 97.54 ± 1.76% release in 30 minutes and the β-CD complex exhibiting 92.47 ± 1.23% release in 15 minutes. SNEDDS tablets showed significantly improved dissolution compared to β-CD-Tadalafil complexes. In pharmacokinetic studies on Wistar rats, SNEEDS resulted in a higher AUC of 4420.6 mcg/ml.hr, C-max of 3.95 mcg/ml, and a faster T-max of 4 hours, indicating enhanced bioavailability in contrast with both the β-CD complexes and the marketed product. The lipophilic system (SNEEDS) was superior to the hydrophilic system (β-CD inclusion complex) in enhancing tadalafil bioavailability. Despite the lower AUC of developed β-CD complex compared to marketed formulation, increased C-max and faster T-max suggested a rapid onset of action and maximum efficacy. In conclusion, the developed lipophilic system – SNEEDS, significantly enhanced tadalafil bioavailability compared to both the hydrophilic system and the marketed product. The optimized SNEDDS formulation exhibited significantly higher dissolution compared with the β-cyclodextrin complex and marketed tablet. This study demonstrates the possibilities of innovative drug delivery systems, especially the lipophilic SEEDS, to address the difficulties related with poorly water-soluble drugs, offers promising avenue to enhance therapeutic efficacy.
DEVELOPMENT OF A NOVEL IN SITU GELLING INTRANASAL SYSTEM CONTAINING RESVERATROL LOADED PLGA NANOPARTICLES FOR MANAGEMENT OF EPILEPSY
, Mihika M. Shringarpure, , Aditi R. Joshi, , Sankalp A. Gharat, , Munira M. Momin, , and
Indian Drugs, 2025
Drug delivery to the brain is highly challenging due to the blood-brain barrier (BBB). Resveratrol (RESV) has antioxidant and neuroprotective effects but limited bioavailability caused by low solubility, photosensitivity and rapid metabolism. This study develops an intranasal in situ gel containing RESVloaded PLGA nanoparticles for targeted nose-to-brain delivery in epilepsy management. The gel uses thermosensitive Kolliphor® P 407, mucoadhesive HPMC K-100, and mannitol for tonicity. It was characterized for particle size, gelation, entrapment efficiency, drug content, and stability and evaluated through in vitro and in vivo studies, offering a promising alternative treatment for epilepsy.
ETODOLAC LOADED MESOPOROUS SILICA NANOPARTICLES BASED TOPICAL GEL FOR TREATMENT OF INFLAMMATION
Jayesh R. Gupta, Shivali A. Nigade, Sankalp A. Gharat, Munira M. Momin, , , , , and
Indian Drugs, 2025
This study explores a topical hydrogel incorporating mesoporous silica nanoparticles (MSNs) loaded with etodolac (ETD) for inflammation treatment. MSNs were synthesized via the sol-gel method and loaded with ETD using adsorption. The ETD-MSNs were formulated into a gel using Carbopol® Ultrez. Characterization confirmed an average size of 254.9 nm, a zeta potential of -38mV, and high porosity. The encapsulation and loading efficiencies were 23.92 % and 28.12 %, respectively. In vitro drug release showed 93.60±1.31 % cumulative release at 8 h. In vivo studies in a Complete Freund’s Adjuvant (CFA) induced arthritic rat model demonstrated significant reduction in inflammation, articular damage and pannus formation. The gel outperformed marketed Proxym® gel in reducing paw edema. Stability studies confirmed no significant changes over 3 months. These findings highlight the potential of ETD-MSN hydrogel as an effective anti-inflammatory treatment with sustained drug release and enhanced therapeutic efficacy.
Design, Formulation, and Evaluation of Opthalmic Multilayer Nanofiber Insert for Management of Dry Eye Disease
Darshana Sakpal, Mayur Mhase, Munira Momin, Sankalp Gharat, Sujata Sawarkar, Sai H. S. Boddu, Moawia Al-Tabakha
Bionanoscience, 2025
Development and preclinical evaluation of a lipomer-based combinatorial delivery system for phytoconstituent and immunosuppressant in the management of Rheumatoid arthritis
Shriya Karmarkar, Gaurav Pandey, Sankalp Gharat, Sujata Sawarkar
Particulate Science and Technology, 2025
Cyclosporine (Cy) is a potent immunosuppressant utilized in the management of rheumatoid arthritis (RA). However, low oral bioavailability and nephrotoxicity limits its use. Curcumin (CU) has been proved to reduce the Cy induced renal toxicity. In response to these challenges, lipomer was selected as a formulation strategy, as it has an edge over nanoemulsions in enhancing transdermal permeability by closely mimicking the cell membrane, while enabling drug release into the synovial fluid. Lipomers loaded with Cy and CU were prepared and evaluated for particle size (105 ± 2.4 nm), zeta potential (−30 ± 0.02 mV) and entrapment efficiency of 79.86% ± 1.223% and 74.40% ± 0.36% for CU and Cy, respectively. The ex-vivo permeation studies exhibited permeation of 99.600% ± 0.57% for CU and 98.684% ± 1.2% for Cy after 24 h. The steady state flux and permeability coefficient was found to be 0.070 µg/cm2/h and 0.026 cm/h for Cy, 0.018 µg/cm2/h and 0.0027 cm/h for CU, respectively. Preclinical studies on Complete Freund’s Adjuvant-induced arthritis rat model demonstrated significant reduction in paw volume, increased RBC, and Hb levels, while reducing WBC levels after treatment. Overall, the results indicate that lipomer-based topical system for delivery of Cy and CU holds as a potential for management of RA.
Novel ethosomal gel formulation for enhanced transdermal delivery of curcumin and cyclosporine: a preclinical approach to rheumatoid arthritis management
Sankalp Gharat, Munira Momin, Urvashi Panchal, Abdelwahab Omri
Drug Delivery, 2025
Vesicular systems have demonstrated efficacy in the management of Rheumatoid Arthritis (RA). This study explores the synergistic effect of edge-activated ethosomal gel to enhance the transdermal delivery of Curcumin (CUR) and Cyclosporine (CYC). Ethosomal vesicles prepared via the ethanol injection method were incorporated into a gel, with the optimized formulation exhibiting an average particle size of 93.3 ± 1.17 nm and a zeta potential of −29.2 ± 0.17 mV. Ex vivo diffusion studies on porcine ear skin demonstrated 97.115 ± 0.40% CUR and 98.331 ± 1.08% CYC release over 18 hours, exhibiting Hixson-Crowell diffusion mechanisms. The steady-state flux and permeability coefficients were 0.095 µg/cm2/hr and 0.0095 cm/hr for CUR, and 0.0804 µg/cm2/hr and 0.01608 cm/hr for CYC respectively. In anti-inflammatory tests on lipopolysaccharide (LPS)-induced RAW 264.7 cells, the gel significantly increased IL-10 levels (p < 0.001), inhibited prostaglandin-E2, and reduced IL-6 and TNF-α levels (p < 0.001). Moreover, the ethosomal gel demonstrated nonirritating properties and exhibited significant reduction in arthritic symptoms in the Complete Freund’s Adjuvant induced 28-day rat model, surpassing the effects of marketed and conventional gel. These findings highlight the synergistic benefits of combining CUR and CYC in an ethosomal gel, offering a promising alternative for RA management. Future clinical investigations are warranted to validate its safety and efficacy in humans and facilitate potential therapeutic integration.
Understanding the role of ethosomes in rheumatoid arthritis: innovative solutions to challenges in transdermal delivery of synthetic drugs and phytoconstituents
Rohan Anchan, Anish Ghadi, Mohammed Ali Chauhan, Angel Godad, Sankalp Gharat
Journal of Drug Targeting, 2025
Rheumatoid Arthritis (RA), an autoimmune disease, is a chronic inflammatory disorder affecting the joints leading to severe damage and cartilage destruction. Current therapies for RA such as DMARDs, NSAIDs, glucocorticoids, and phytoconstituents often face challenges related to solubility and transdermal permeability. Considering the barriers posed by the stratum corneum in transdermal drug delivery, ethosomes have shown promising results in overcoming these hurdles. The presence of ethanol in ethosomes imparts flexibility and disrupts the skin's lipid bilayer, allowing for transdermal penetration. Researchers have explored the potential of ethosomal drug delivery systems loaded with various synthetic drugs and phytoconstituents for the management of RA. Despite promising preclinical findings, these systems have yet to transition from the bench to the bedside, and there is a lack of comprehensive review papers highlighting the potential of ethosomes in RA treatment. Considering the commercial challenges in scaling up such nano systems, this review aims to analyse the current state of the art and advancements in ethosomal formulations loaded with synthetic agents and phytoconstituents. Further, it explores the impact of excipients and processing parameters, on the preparation of ethosomes and their efficacy in overcoming skin barriers, to enhance the permeability of therapeutic agents.
Navigating rheumatoid arthritis: insights into ligand-anchored nanoparticle strategies for anti-inflammatory therapy and relief
Shriya Karmarkar, Trinette Fernandes, Zainab Choonia, Sankalp Gharat, Sujata Sawarkar
Rsc Pharmaceutics, 2024
Ligand-based nanotechnology is promising in enhancing targeted drug delivery in autoimmune disorders. This study explores molecular targets and new active targeting techniques. These technologies enhance drug specificity via precise targeting.
Development and preclinical assessment of nanoemulgel loaded with phytoconstituents for the management of rheumatoid arthritis
Anita Chando, Vivek Basudkar, Sankalp Gharat, Munira Momin, Tabassum Khan
Drug Delivery and Translational Research, 2024
Correction: Development and preclinical assessment of nanoemulgel loaded with phytoconstituents for the management of rheumatoid arthritis (Drug Delivery and Translational Research, (2024), 14, 2, (524-541), 10.1007/s13346-023-01416-6)
Anita Chando, Vivek Basudkar, Sankalp Gharat, Munira Momin, Tabassum Khan
Drug Delivery and Translational Research, 2024
Viral therapy for targeted drug delivery to cancers: Recent advances, clinical and regulatory perspectives
Kanaka Dhuri, Sankalp Gharat, Nikita Fernandes, Vivek Basudkar, Gaurav Doshi, Munira Momin
Journal of Drug Delivery Science and Technology, 2024
Advances in hydrogels based cutaneous drug delivery system for management of psoriasis
Taher Vasowala, Sankalp Gharat, Mayur Mhase, Munira Momin
European Polymer Journal, 2024
Pharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems: From Basic Concepts to Applications: A Machine-Generated Literature Overview
Pharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems from Basic Concepts to Applications A Machine Generated Literature Overview, 2024
Fluocinolone Acetonide Loaded Chitosan Nanofiber Scaffolds for Treatment of Ocular Disorders: In Vitro Characterization, Ex-Vivo Corneal and Ex-Vivo Scleral Evaluation
Zeeshan Patel, Sankalp Gharat, Munira Momin
Current Eye Research, 2024
Unraveling the Role of the Glycogen Synthase Kinase-3β, Bruton’s Tyrosine Kinase, and Sphingosine 1 Phosphate Pathways in Multiple Sclerosis
Rupali Mohite, Sankalp Gharat, Gaurav Doshi
Endocrine Metabolic and Immune Disorders Drug Targets, 2024
In-Vitro and in-Vivo Evaluation of the Developed Curcumin-Cyclosporine-Loaded Nanoemulgel for the Management of Rheumatoid Arthritis
Sankalp Gharat, Vivek Basudkar, Munira Momin
Immunological Investigations, 2024
FORMULATION AND DEVELOPMENT OF BIOADHESIVE PELLETS FOR MANAGEMENT OF HELICOBACTER PYLORI INFECTION
Raj Khatri, , Munira Momin, Sankalp Gharat, Mansi Damani, , , and
Indian Drugs, 2024
New Insights in Psoriasis Management using Herbal Drug Nanocarriers
Shreyas P. Salgaonkar, Japneet Singh Purewal, Gaurav Mahesh Doshi, Sankalp Gharat, Trinette Fernandes, Sujata P. Sawarkar
Current Pharmaceutical Design, 2024
Innovative drug delivery strategies for targeting glioblastoma: overcoming the challenges of the tumor microenvironment
Sidra Khot, Anandha Krishnaveni, Sankalp Gharat, Munira Momin, Chintan Bhavsar, Abdelwahab Omri
Expert Opinion on Drug Delivery, 2024
Mucoadhesive Oro-Gel–Containing Chitosan Lipidic Nanoparticles for the Management of Oral Squamous Cell Carcinoma
Sankalp Gharat, Vivek Basudkar, Munira Momin, Arati Prabhu
Journal of Pharmaceutical Innovation, 2023
Unravelling the potential of nanocarriers to deliver Curcumin for the management of Rheumatoid Arthritis
Sankalp Gharat, Aditya Pandya, Duttraj Kulkarni, Munira Momin
Journal of Drug Delivery Science and Technology, 2023
QUANTITATIVE ESTIMATION OF 6-GINGEROL, E-GUGGULSTERONE AND Z-GUGGULSTERONE IN A FIXED DOSE COMBINATION NANOEMULGEL BY RP-HPLC
Munira Momin, , Vivek Basudkar, Sankalp Gharat, Anita D. Chando, Tabassum Khan
Indian Drugs, 2023
Exploring Cytokines as Potential Target in Peptic Ulcer Disease: A Systematic Update
Gaurav Mahesh Doshi, Alveera Zubair Ansari, Nirav Yogesh Bhatia, Sankalp Ashok Gharat, Angel Pavalu Godad
Endocrine Metabolic and Immune Disorders Drug Targets, 2023
Modification and Functionalization of Polymers for Targeting to Bone Cancer and Bone Regeneration
Yogesh Nimbalkar, Sankalp A. Gharat, Vidhi Tanna, Vandana S. Nikam, Swapna Nabar, Sujata P. Sawarkar
Critical Reviews in Biomedical Engineering, 2023
Recent advancements in polymeric nanofibers for ophthalmic drug delivery and ophthalmic tissue engineering
Darshana Sakpal, Sankalp Gharat, Munira Momin
Biomaterials Advances, 2022
An update on novel therapeutic intervention in Rheumatoid arthritis
Pritha Shah, Aqsa Siddique, Ami Thakkar, Sankalp Gharat, Angel Godad, Pravin Kale, Gaurav Doshi
International Immunopharmacology, 2022
A Review of Anti-Aging Nanoformulations: Recent Developments in Excipients for Nanocosmeceuticals and Regulatory Guidelines
Vivek Basudkar, Sankalp A. Gharat, Munira M. Momin, Mihika Shringarpure
Critical Reviews in Therapeutic Drug Carrier Systems, 2022
Recent Advancements in Electrospun Nanofibers for Wound Healing: Polymers, Clinical and Regulatory Perspective
Zeeshan Patel, Sankalp A. Gharat, Moawia M. Al-Tabakha, Akram Ashames, Sai H. S. Boddu, Munira M. Momin
Critical Reviews in Therapeutic Drug Carrier Systems, 2022
Cellulosic polymers for enhancing drug bioavailability in ocular drug delivery systems
Bharti Gupta, Varsha Mishra, Sankalp Gharat, Munira Momin, Abdelwahab Omri
Pharmaceuticals, 2021
Recent advancements in cellulose-based biomaterials for management of infected wounds
Munira Momin, Varsha Mishra, Sankalp Gharat, Abdelwahab Omri
Expert Opinion on Drug Delivery, 2021
Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery
Mihika Shringarpure, Sankalp Gharat, Munira Momin, Abdelwahab Omri
Expert Opinion on Drug Delivery, 2021
Metallic nanoparticles as drug delivery system for the treatment of cancer
Neha Desai, Munira Momin, Tabassum Khan, Sankalp Gharat, Raghumani Singh Ningthoujam, Abdelwahab Omri
Expert Opinion on Drug Delivery, 2021
Functionalized and graft copolymers of chitosan and its pharmaceutical applications
Chintan Bhavsar, Munira Momin, Sankalp Gharat, Abdelwahab Omri
Expert Opinion on Drug Delivery, 2017
Oral squamous cell carcinoma: Current treatment strategies and nanotechnology-based approaches for prevention and therapy
Sankalp A. Gharat, Munira Momin, Chintan Bhavsar
Critical Reviews in Therapeutic Drug Carrier Systems, 2016

RECENT SCHOLAR PUBLICATIONS

Pharmacokinetic and Dissolution Profiling of Tadalafil Formulated with SNEDDS and β-Cyclodextrin in Fast-Dissolving Tablets
C Jose, S Gharat, A Baig, P Pilgaokar, M Momin
Drug Development and Industrial Pharmacy, 1-22 , 2026
2026
Optimization of Nanostructured Lipid Carrier Using Central Composite Design for Ocular Delivery of Pirfenidone
V Basudkar, S Gharat, A Baig, M Momin
Journal of Pharmaceutical Innovation 21 (1), 92 , 2026
2026
Novel ethosomal gel formulation for enhanced transdermal delivery of curcumin and cyclosporine: a preclinical approach to rheumatoid arthritis management
S Gharat, M Momin, U Panchal, A Omri
Drug Delivery 32 (1), 2512620 , 2025
2025
Citations: 15
Understanding the role of ethosomes in rheumatoid arthritis: innovative solutions to challenges in transdermal delivery of synthetic drugs and phytoconstituents
R Anchan, A Ghadi, MA Chauhan, A Godad, S Gharat
Journal of Drug Targeting 33 (8), 1247-1261 , 2025
2025
Citations: 3
DEVELOPMENT OF A NOVEL IN SITU GELLING INTRANASAL SYSTEM CONTAINING RESVERATROL LOADED PLGA NANOPARTICLES FOR MANAGEMENT OF EPILEPSY
MM Shringarpure, AR Joshi, SA Gharat, MM Momin
Indian Drugs 62 (09), 23 , 2025
2025
ETODOLAC LOADED MESOPOROUS SILICA NANOPARTICLES BASED TOPICAL GEL FOR TREATMENT OF INFLAMMATION.
JR Gupta, SA Nigade, SA Gharat, MM Momin
Indian Drugs 62 (6) , 2025
2025
Development and preclinical evaluation of a lipomer-based combinatorial delivery system for phytoconstituent and immunosuppressant in the management of Rheumatoid arthritis
S Karmarkar, G Pandey, S Gharat, S Sawarkar
Particulate Science and Technology 43 (4), 501-513 , 2025
2025
Design, Formulation, and Evaluation of Opthalmic Multilayer Nanofiber Insert for Management of Dry Eye Disease
D Sakpal, M Mhase, M Momin, S Gharat, S Sawarkar, SHS Boddu, ...
Bionanoscience 15 (1), 97 , 2025
2025
Citations: 3
Navigating rheumatoid arthritis: insights into ligand-anchored nanoparticle strategies for anti-inflammatory therapy and relief
S Karmarkar, T Fernandes, Z Choonia, S Gharat, S Sawarkar
RSC Pharmaceutics 2 (1), 19-43 , 2025
2025
Citations: 8
Innovative drug delivery strategies for targeting glioblastoma: overcoming the challenges of the tumor microenvironment
S Khot, A Krishnaveni, S Gharat, M Momin, C Bhavsar, A Omri
Expert Opinion on Drug Delivery 21 (12), 1837-1857 , 2024
2024
Citations: 21
New insights in psoriasis management using herbal drug nanocarriers
SP Salgaonkar, JS Purewal, GM Doshi, T Fernandes, S Gharat, ...
Current Pharmaceutical Design 30 (32), 2550-2561 , 2024
2024
Citations: 6
Introduction to pharmacokinetics and pharmacodynamic studies of novel drug delivery systems
SA Gharat, MM Momin, T Khan
Pharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems: From … , 2024
2024
Citations: 3
Pharmacokinetic, Pharmacodynamic, Preclinical and Clinical Models for Evaluation of Nanoparticles
SA Gharat, MM Momin, T Khan
Pharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems: From … , 2024
2024
Citations: 5
Absorption, Distribution, Metabolism and Excretion of Novel Drug Delivery Systems
SA Gharat, MM Momin, T Khan
Pharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems: From … , 2024
2024
Citations: 1
Clinical Applications of Pharmacokinetic and Pharmacodynamic Studies of Targeted Novel Drug Delivery Systems
SA Gharat, MM Momin, T Khan
Pharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems: From … , 2024
2024
Citations: 2
Pharmacokinetics and pharmacodynamics of nanocarriers and novel drug delivery systems
SA Gharat, MM Momin, T Khan
Pharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems: From … , 2024
2024
Citations: 6
Artificial intelligence and machine learning in pharmacokinetics and pharmacodynamic studies
SA Gharat, MM Momin, T Khan
Pharmacokinetics and pharmacodynamics of novel drug delivery systems: from … , 2024
2024
Citations: 3
Pharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems: From Basic Concepts to Applications: A Machine-Generated Literature Overview
SA Gharat, MM Momin, T Khan
Springer Nature Singapore , 2024
2024
Citations: 7
Unraveling the Role of the Glycogen Synthase Kinase-3β, Bruton’s Tyrosine Kinase, and Sphingosine 1 Phosphate Pathways in Multiple Sclerosis
R Mohite, S Gharat, G Doshi
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug … , 2024
2024
Citations: 1
Fluocinolone Acetonide Loaded Chitosan Nanofiber Scaffolds for Treatment of Ocular Disorders: In Vitro Characterization, Ex-Vivo Corneal and Ex-Vivo Scleral …
Z Patel, S Gharat, M Momin
Current Eye Research 49 (5), 467-476 , 2024
2024
Citations: 3

MOST CITED SCHOLAR PUBLICATIONS

Oral squamous cell carcinoma: current treatment strategies and nanotechnology-based approaches for prevention and therapy
SA Gharat, MM Momin, C Bhavsar
Critical Reviews™ in Therapeutic Drug Carrier Systems 33 (4) , 2016
2016
Citations: 275
Metallic nanoparticles as drug delivery system for the treatment of cancer
N Desai, M Momin, T Khan, S Gharat, RS Ningthoujam, A Omri
Expert opinion on drug delivery 18 (9), 1261-1290 , 2021
2021
Citations: 232
Cellulosic polymers for enhancing drug bioavailability in ocular drug delivery systems
B Gupta, V Mishra, S Gharat, M Momin, A Omri
Pharmaceuticals 14 (11), 1201 , 2021
2021
Citations: 157
Functionalized and graft copolymers of chitosan and its pharmaceutical applications
C Bhavsar, M Momin, S Gharat, A Omri
Expert opinion on drug delivery 14 (10), 1189-1204 , 2017
2017
Citations: 115
Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery
M Shringarpure, S Gharat, M Momin, A Omri
Expert Opinion on Drug Delivery 18 (2), 169-185 , 2021
2021
Citations: 74
Recent advancements in polymeric nanofibers for ophthalmic drug delivery and ophthalmic tissue engineering
D Sakpal, S Gharat, M Momin
Biomaterials advances 141, 213124 , 2022
2022
Citations: 48
An update on novel therapeutic intervention in Rheumatoid arthritis
P Shah, A Siddique, A Thakkar, S Gharat, A Godad, P Kale, G Doshi
International Immunopharmacology 109, 108794 , 2022
2022
Citations: 30
Recent advancements in electrospun nanofibers for wound healing: polymers, clinical and regulatory perspective
Z Patel, SA Gharat, MM Al-Tabakha, A Ashames, SHS Boddu, MM Momin
Critical Reviews™ in Therapeutic Drug Carrier Systems 39 (4) , 2022
2022
Citations: 26
A review of anti-aging nanoformulations: recent developments in excipients for nanocosmeceuticals and regulatory guidelines
V Basudkar, SA Gharat, MM Momin, M Shringarpure
Critical Reviews™ in Therapeutic Drug Carrier Systems 39 (3) , 2022
2022
Citations: 25
Recent advancements in cellulose-based biomaterials for management of infected wounds
M Momin, V Mishra, S Gharat, A Omri
Expert Opinion on Drug Delivery 18 (11), 1741-1760 , 2021
2021
Citations: 25
Innovative drug delivery strategies for targeting glioblastoma: overcoming the challenges of the tumor microenvironment
S Khot, A Krishnaveni, S Gharat, M Momin, C Bhavsar, A Omri
Expert Opinion on Drug Delivery 21 (12), 1837-1857 , 2024
2024
Citations: 21
Advances in hydrogels based cutaneous drug delivery system for management of psoriasis
T Vasowala, S Gharat, M Mhase, M Momin
European Polymer Journal 202, 112630 , 2024
2024
Citations: 21
Novel ethosomal gel formulation for enhanced transdermal delivery of curcumin and cyclosporine: a preclinical approach to rheumatoid arthritis management
S Gharat, M Momin, U Panchal, A Omri
Drug Delivery 32 (1), 2512620 , 2025
2025
Citations: 15
In-vitro and in-vivo evaluation of the developed curcumin-cyclosporine-loaded nanoemulgel for the management of rheumatoid arthritis
S Gharat, V Basudkar, M Momin
Immunological Investigations 53 (3), 490-522 , 2024
2024
Citations: 14
Exploring cytokines as potential target in peptic ulcer disease: A systematic update
AZ Ansari, NY Bhatia, SA Gharat, AP Godad, GM Doshi
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug … , 2023
2023
Citations: 12
Development and preclinical assessment of nanoemulgel loaded with phytoconstituents for the management of rheumatoid arthritis
A Chando, V Basudkar, S Gharat, M Momin, T Khan
Drug Delivery and Translational Research 14 (2), 524-541 , 2024
2024
Citations: 9
Navigating rheumatoid arthritis: insights into ligand-anchored nanoparticle strategies for anti-inflammatory therapy and relief
S Karmarkar, T Fernandes, Z Choonia, S Gharat, S Sawarkar
RSC Pharmaceutics 2 (1), 19-43 , 2025
2025
Citations: 8
Pharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems: From Basic Concepts to Applications: A Machine-Generated Literature Overview
SA Gharat, MM Momin, T Khan
Springer Nature Singapore , 2024
2024
Citations: 7
Mucoadhesive oro-gel–containing chitosan lipidic nanoparticles for the management of oral squamous cell carcinoma
S Gharat, V Basudkar, M Momin, A Prabhu
Journal of Pharmaceutical Innovation 18 (3), 1298-1315 , 2023
2023
Citations: 7
New insights in psoriasis management using herbal drug nanocarriers
SP Salgaonkar, JS Purewal, GM Doshi, T Fernandes, S Gharat, ...
Current Pharmaceutical Design 30 (32), 2550-2561 , 2024
2024
Citations: 6

Sankalp Ashok Gharat

RESEARCH INTERESTS

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

MOST CITED SCHOLAR PUBLICATIONS